Enlivex ENLV
NASDAQ ENLV
$1.48 -0.02 (-1.67%)
As of: Aug 21, 2026 · 12:50 PM EDT

Enlivex (ENLV) Receivables - Net (2013 - 2018)

Enlivex (ENLV) posted quarterly Receivables - Net of $488000.0 for Q4 2018, up 408.33% year-over-year from $96000.0 in Q4 2017, and up 1526.67% quarter-over-quarter from $30000.0 in Q2 2018.

Enlivex (ENLV) Receivables - Net (2013 - 2018) Analysis & Trends

Enlivex's Receivables - Net history runs 6 years deep, the most recent figure standing at $488000.0 for Q4 2018.

  • In Q4 2018, Receivables - Net rose 408.33% year-over-year to $488000.0; the TTM figure through Dec 2018 stood at $488000.0 (up 408.33% YoY), while the FY2018 annual figure was $488000.0, up 408.33% from the prior year.
  • Receivables - Net for Q4 2018 stood at $488000.0, up from $30000.0 in the prior quarter.
  • The five-year high for Receivables - Net was $1.1 million in Q2 2016, with the low at -$786000.0 in Q4 2015.
  • The 5-year median for Receivables - Net is $488000.0 (2018), against an average of $384000.0.
  • The sharpest annual moves came in 2015 and 2018: Receivables - Net slumped 945.16% in 2015, then surged 408.33% in 2018.
  • Enlivex's Receivables - Net stood at $93000.0 in 2014, then plunged by 945.16% to -$786000.0 in 2015, then surged by 106.62% to $52000.0 in 2016, then soared by 84.62% to $96000.0 in 2017, then soared by 408.33% to $488000.0 in 2018.
  • Business Quant data shows ENLV's Receivables - Net at $488000.0 in Q4 2018, $30000.0 in Q2 2018, and $96000.0 in Q4 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn
9 Royalty Pharma 27.31 Bn 26.47 Bn -
10 Enlivex 4.49 Mn -1.26 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2018 488,000.00
Dec 31, 2018 488,000.00
Jun 30, 2018 30,000.00
Jun 30, 2018 30,000.00
Dec 31, 2017 96,000.00
Dec 31, 2017 96,000.00
Sep 30, 2017 502,000.00
Sep 30, 2017 502,000.00
Jun 30, 2017 342,000.00
Jun 30, 2017 342,000.00
Mar 31, 2017 682,000.00
Mar 31, 2017 682,000.00
Dec 31, 2016 52,000.00
Dec 31, 2016 52,000.00
Sep 30, 2016 728,000.00
Sep 30, 2016 728,000.00
Jun 30, 2016 1.09 Mn
Jun 30, 2016 1.09 Mn
Mar 31, 2016 722,000.00
Mar 31, 2016 722,000.00